Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pure Bioscience, Inc. (PURE) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pure Bioscience, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1006028.
Total stock buying since 2014: $8,738,565.
Total stock sales since 2014: $284,303.
Total stock option exercises since 2014: $258,372.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 60,000 | $9,050 | 0 | $0 | 0 | $0 |
| 2022 | 269,477 | $49,371 | 0 | $0 | 0 | $0 |
| 2021 | 35,998 | $15,515 | 0 | $0 | 0 | $0 |
| 2020 | 333,878 | $497,688 | 748,880 | $217,175 | 0 | $0 |
| 2019 | 3,431,237 | $1,043,159 | 40,000 | $11,200 | 0 | $0 |
| 2018 | 2,336,187 | $1,051,284 | 41,500 | $38,653 | 0 | $0 |
| 2017 | 18,666,666 | $0 | 18,669,967 | $3,135 | 511,732 | $258,372 |
| 2016 | 0 | $0 | 14,885 | $14,140 | 0 | $0 |
| 2015 | 13,333,333 | $5,999,999 | 0 | $0 | 0 | $0 |
| 2014 | 85,294 | $72,499 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-03 | 60,000 | $9,050 | 0 | $0 | 0 | $0 |
| 2022-12 | 50,000 | $6,550 | 0 | $0 | 0 | $0 |
| 2022-03 | 219,477 | $42,821 | 0 | $0 | 0 | $0 |
| 2021-06 | 35,998 | $15,515 | 0 | $0 | 0 | $0 |
| 2020-12 | 78,721 | $52,246 | 748,880 | $217,175 | 0 | $0 |
| 2020-06 | 255,157 | $445,442 | 0 | $0 | 0 | $0 |
| 2019-12 | 754,884 | $218,161 | 40,000 | $11,200 | 0 | $0 |
| 2019-10 | 1,862,068 | $539,999 | 0 | $0 | 0 | $0 |
| 2019-05 | 814,285 | $284,999 | 0 | $0 | 0 | $0 |
| 2018-08 | 2,336,187 | $1,051,284 | 0 | $0 | 0 | $0 |
| 2018-01 | 0 | $0 | 41,500 | $38,653 | 0 | $0 |
| 2017-12 | 18,666,666 | $0 | 18,666,666 | $0 | 0 | $0 |
| 2017-09 | 0 | $0 | 0 | $0 | 511,732 | $258,372 |
| 2017-04 | 0 | $0 | 3,301 | $3,135 | 0 | $0 |
| 2016-12 | 0 | $0 | 14,885 | $14,140 | 0 | $0 |
| 2015-10 | 13,333,333 | $5,999,999 | 0 | $0 | 0 | $0 |
| 2014-08 | 20,000 | $17,000 | 0 | $0 | 0 | $0 |
| 2014-07 | 65,294 | $55,499 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-03-22 | Bartlett Robert F (CEO) | Buy | 50,000 | .15 | 7,750 |
| 2023-03-21 | Blotner Bernard (Director) | Buy | 10,000 | .13 | 1,300 |
| 2022-12-15 | Lee Tom Y (Chief Executive Officer) | Buy | 50,000 | .13 | 6,550 |
| 2022-03-21 | Lee Tom Y (Chief Executive Officer) | Buy | 185,000 | .20 | 36,630 |
| 2022-03-17 | Lee Tom Y (Chief Executive Officer) | Buy | 13,250 | .18 | 2,371 |
| 2022-03-16 | Lee Tom Y (Chief Executive Officer) | Buy | 21,227 | .18 | 3,820 |
| 2021-06-16 | Lee Tom Y (Chief Executive Officer) | Buy | 35,998 | .43 | 15,515 |
| 2020-12-24 | Lee Tom Y (Chief Executive Officer) | Buy | 851 | .65 | 553 |
| 2020-12-22 | Lee Tom Y (Chief Executive Officer) | Buy | 45,299 | .66 | 29,987 |
| 2020-12-21 | Lee Tom Y (Chief Executive Officer) | Buy | 7,859 | .68 | 5,344 |
| 2020-12-19 | Okuno Dale (Director) | Sale | 748,880 | .29 | 217,175 |
| 2020-12-17 | Lee Tom Y (Chief Executive Officer) | Buy | 4,712 | .65 | 3,062 |
| 2020-12-16 | Lee Tom Y (Chief Executive Officer) | Buy | 20,000 | .67 | 13,300 |
| 2020-06-22 | Lee Tom Y (Chief Executive Officer) | Buy | 13,124 | 1.72 | 22,573 |
| 2020-06-19 | Lee Tom Y (Chief Executive Officer) | Buy | 10,000 | 1.85 | 18,500 |
| 2020-06-18 | Lee Tom Y (Chief Executive Officer) | Buy | 30,000 | 1.75 | 52,500 |
| 2020-06-17 | Lee Tom Y (Chief Executive Officer) | Buy | 26,876 | 1.60 | 43,135 |
| 2020-06-16 | Lee Tom Y (Chief Executive Officer) | Buy | 70,000 | 1.62 | 113,330 |
| 2020-06-15 | Lee Tom Y (Chief Executive Officer) | Buy | 60,000 | 1.82 | 109,200 |
| 2020-06-12 | Lee Tom Y (Chief Executive Officer) | Buy | 45,157 | 1.91 | 86,204 |
| 2019-12-31 | Okuno Dale (Director) | Sale | 40,000 | .28 | 11,200 |
| 2019-12-19 | Lee Tom Y (Director) | Buy | 754,884 | .29 | 218,161 |
| 2019-10-02 | Lee Tom Y (Director) | Buy | 1,000,000 | .29 | 290,000 |
| 2019-10-02 | Okuno Dale (Director) | Buy | 862,068 | .29 | 249,999 |
| 2019-05-09 | Chen Ivan (Director) | Buy | 100,000 | .35 | 35,000 |
| 2019-05-09 | Okuno Dale (Director) | Buy | 714,285 | .35 | 249,999 |
| 2018-08-16 | Lee Tom Y (Director) | Buy | 2,336,187 | .45 | 1,051,284 |
| 2018-01-12 | Lambert Henry R. (Chief Executive Officer) | Sale | 21,000 | .92 | 19,383 |
| 2018-01-11 | Lambert Henry R. (Chief Executive Officer) | Sale | 2,000 | .94 | 1,880 |
| 2018-01-10 | Lambert Henry R. (Chief Executive Officer) | Sale | 18,500 | .94 | 17,390 |
| 2017-12-29 | Lee Tom Y (Director) | Buy | 18,666,666 | .00 | 0 |
| 2017-12-29 | Franchise Brands, Llc (10% Owner) | Sale | 18,666,666 | .00 | 0 |
| 2017-09-25 | Lee Tom Y (Director) | Option Ex | 486,666 | .50 | 243,333 |
| 2017-09-25 | Otis William (Director) | Option Ex | 9,066 | .60 | 5,439 |
| 2017-09-25 | Pfanzelter David J (Chairman of the Board) | Option Ex | 16,000 | .60 | 9,600 |
| 2017-04-12 | Lambert Henry R. (Chief Executive Officer) | Sale | 1,500 | .95 | 1,425 |
| 2017-04-11 | Lambert Henry R. (Chief Executive Officer) | Sale | 1,801 | .95 | 1,710 |
| 2016-12-21 | Lee Tom Y (Director) | Sale | 14,885 | .95 | 14,140 |
| 2015-10-23 | Franchise Brands, Llc (10% Owner) | Buy | 13,333,333 | .45 | 5,999,999 |
| 2014-08-01 | Otis William (Director) | Buy | 20,000 | .85 | 17,000 |
| 2014-07-18 | Theno David M (Director) | Buy | 30,000 | .85 | 25,500 |
| 2014-07-02 | Pfanzelter David J (Director) | Buy | 35,294 | .85 | 29,999 |
Insider trading activities including stock purchases, stock sales, and option exercises of PURE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pure Bioscience, Inc. (symbol PURE, CIK number 1006028) see the Securities and Exchange Commission (SEC) website.